Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Enphase Energy | ENPH | Nov 25, 2024 | 71.91 | +8.48 |
Enpro | NPO | Nov 25, 2024 | 189.03 | +2.61 |
Enservco | ENSV | Nov 25, 2024 | 0.04 | -12.09 |
Enstar Group | ESGR | Nov 25, 2024 | 325.38 | +0.21 |
Enstar Group Depository E Pref | ESGRO | Nov 25, 2024 | 20.34 | +2.32 |
Enstar Pref | ESGRP | Nov 25, 2024 | 19.95 | +1.89 |
Ensysce Biosciences | ENSC | Nov 25, 2024 | 0.48 | +11.35 |
Entegris | ENTG | Nov 25, 2024 | 108.02 | +0.73 |
Entera Bio | ENTX | Nov 25, 2024 | 1.67 | +5.03 |
Entergy | ETR | Nov 25, 2024 | 152.50 | +0.95 |
Entergy Texas A Pref | ETI- | Nov 25, 2024 | 24.73 | +0.48 |
Entergy Utility Enterprises | EMP | Nov 25, 2024 | 22.24 | +0.68 |
Entero Therapeutics | ENTO | Nov 25, 2024 | 0.47 | +3.90 |
Enterprise Bancorp | EBTC | Nov 25, 2024 | 37.42 | +1.49 |
Enterprise Financial Services | EFSC | Nov 25, 2024 | 61.38 | +1.05 |
Enterprise Financial Services A Pref | EFSCP | Nov 25, 2024 | 20.36 | -0.67 |
Enterprise Products Partners LP Unit | EPD | Nov 25, 2024 | 32.34 | -1.46 |
Entrada Therapeutics | TRDA | Nov 25, 2024 | 19.04 | +1.28 |
Entravision Communications | EVC | Nov 25, 2024 | 2.45 | -2.00 |
Envela | ELA | Nov 25, 2024 | 6.43 | -1.08 |
Enveric Biosciences | ENVB | Nov 25, 2024 | 0.32 | -3.42 |
Envestnet | ENV | Nov 25, 2024 | 63.14 | 0.00 |
Enviri | NVRI | Nov 25, 2024 | 7.45 | +1.22 |
Environmental Svcs ETF Market Vectors | EVX | Nov 25, 2024 | 191.11 | +1.34 |
Envirotech Vehicles | EVTV | Nov 25, 2024 | 1.40 | 0.00 |
Envista | NVST | Nov 25, 2024 | 22.18 | +3.26 |
Envoy Medical A | COCH | Nov 25, 2024 | 2.15 | -1.38 |
enVVeno Medical | NVNO | Nov 25, 2024 | 3.40 | -0.29 |
Enzo Biochem | ENZ | Nov 25, 2024 | 0.97 | +0.52 |
EOG Resources | EOG | Nov 25, 2024 | 131.98 | -3.21 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.